During the 8th Microbiome Movement – Drug Development Summit, held in London at the end of January, MicrobiomePost discussed with Claire Derlot, Head of Programs at Biose Industrie, the GMP challenges when you have to go from bacteria to a drug. Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialisedin Live Biotherapeutic Products.
How Biose Industrie Makes the Difference in LBP Process Development & GMP Production
MicrobiomePost discussed with Claire Derlot, Head of Programs at Biose Industrie, the GMP challenges when you have to go from bacteria to a drug.
Latest related content
